Join to View Full Profile
600 Highland AveMadison, WI 53792
Phone+1 608-263-4757
Fax+1 608-265-8852
Dr. Jarrard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Minimally Invasive Urologic Surgery, 1994 - 1996
University of ChicagoResidency, Urology, 1990 - 1994
University of ChicagoInternship, Transitional Year, 1989 - 1990
University of Virginia School of MedicineClass of 1989
Certifications & Licensure
WI State Medical License 1996 - 2027
IL State Medical License 2021 - 2026
MD State Medical License 1994 - 1996
American Board of Urology Urology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
Clinical Trials
- S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate Start of enrollment: 2000 Feb 01
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer Start of enrollment: 2006 Sep 26
- Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer Start of enrollment: 2011 Dec 01
Publications & Presentations
PubMed
- Understanding the role of statin use on advanced prostate cancer outcomes: Does the statin type, cumulative dose, or duration impact survival?Alexa Rose León, Michael Risk, William A Ricke, Jinn-Ing Liou, David F Jarrard
Urologic Oncology. 2026-02-01 - 2 citationsProstate zonal impact of 5α-reductase inhibitors on multiparametric MRI characteristics and detection of prostate cancer.Arighno Das, Marcelo Bigarella, Krista Brackman, Glenn O Allen, Soroush Rais-Bahrami
BJU International. 2026-02-01 - Percutaneous Microwave Ablation Preserves Renal Function with Similar Long Term Oncologic Outcomes Compared to Surgery for Clinical T1 Renal Cell Carcinoma.Daniel F Roadman, Daniel D Shapiro, Arighno Das, Leslie W Nelson, Paz Lotan
Cancers. 2026-01-21
Journal Articles
- The Impact of Statins in Combination with Androgen Deprivation Therapyin Patients with Advanced Prostate Cancer: A Large Observational StudyNatasza Posielski, Tariq A Khemees, David F Jarrard, Kyle A Richards, Urologic Oncology
Authored Content
- SUO 2020: Drug Intervention for Active Surveillance with ApalutamideDecember 2020
- The Impact of Statins in Combination with Androgen Deprivation Therapyin Patients with Advanced Prostate Cancer: A Large Observational StudyDecember 2018
Press Mentions
Quick Restart of US Hospitals Challenged by Patient Fears: National SurveyMay 5th, 2020
AUA 2019: Second Opinion Cases (Ask the Guidelines!): Castration Resistant Prostate CancerMay 4th, 2019
Study Provides Cellular Explanation for Higher Risk of Prostate Cancer in Aging MenAugust 24th, 2017
Grant Support
- University of Wisconsin Prostate SPOREUNIVERSITY OF WISCONSIN-MADISON2023–2030
- Sequence-specific Hybridization Capture for Discovery of Proteoform–lncRNA Interactions in Prostate CancerUNIVERSITY OF WISCONSIN-MADISON2015–2025
- Modulation Of IGF-II Imprinting In The Aging ProstateNational Cancer Institute2002–2012
- Modulation Of IGF-II Imprinting In The Aging ProstateNational Cancer Institute2008
- Mechanisms For Acquired Changes In Prostate Growth RegulationNational Institute Of Diabetes And Digestive And Kidney Diseases2007
Professional Memberships
- Member
- Member
- Society for Urological OncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
